Prelude Therapeutics's total assets for Q3 2025 were $94.75M, a decrease of ― from the previous quarter. PRLD total liabilities were $36.22M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.